Literature DB >> 32244293

Aspirin: A Suicide Inhibitor of Carbonic Anhydrase II.

Jacob Andring1, Jacob Combs1, Robert McKenna1.   

Abstract

Carbonic anhydrase II (CAII) is a metalloenzyme that catalyzes the reversible hydration/dehydration of CO2/HCO3-. In addition, CAII is attributed to other catalytic reactions, including esterase activity. Aspirin (acetyl-salicylic acid), an everyday over-the-counter drug, has both ester and carboxylic acid moieties. Recently, compounds with a carboxylic acid group have been shown to inhibit CAII. Hence, we hypothesized that Aspirin could act as a substrate for esterase activity, and the product salicylic acid (SA), an inhibitor of CAII. Here, we present the crystal structure of CAII in complex with SA, a product of CAII crystals pre-soaked with Aspirin, to 1.35Å resolution. In addition, we provide kinetic data to support the observation that CAII converts Aspirin to its deacetylated form, SA. This data may also explain the short half-life of Aspirin, with CAII so abundant in blood, and that Aspirin could act as a suicide inhibitor of CAII.

Entities:  

Keywords:  Aspirin; X-ray crystallography; carbonic anhydrase; esterase; salicylic acid

Year:  2020        PMID: 32244293     DOI: 10.3390/biom10040527

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  3 in total

1.  Comments to the Editor Due to the Response by the Supuran Group to Our Article.

Authors:  Bengt-Harald Jonsson; Anders Liljas
Journal:  Biophys J       Date:  2020-12-13       Impact factor: 4.033

2.  Inhibition studies of bacterial α-carbonic anhydrases with phenols.

Authors:  Simone Giovannuzzi; Chad S Hewitt; Alessio Nocentini; Clemente Capasso; Gabriele Costantino; Daniel P Flaherty; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

3.  Inhibition studies of the protozoan α-carbonic anhydrase from Trypanosoma cruzi with phenols.

Authors:  Alessandro Bonardi; Seppo Parkkila; Claudiu T Supuran
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.